BioHarvest Sciences Inc. Common Stock
BHST · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $25 | $13 | $5 | $2 |
| % Growth | 98.8% | 130.5% | 161.6% | – |
| Cost of Goods Sold | $11 | $7 | $4 | $1 |
| Gross Profit | $14 | $6 | $1 | $1 |
| % Margin | 55.4% | 44.5% | 22.2% | 31.9% |
| R&D Expenses | $5 | $3 | $2 | $4 |
| G&A Expenses | $6 | $6 | $5 | $2 |
| SG&A Expenses | $16 | $12 | $9 | $5 |
| Sales & Mktg Exp. | $9 | $6 | $4 | $3 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $21 | $16 | $12 | $9 |
| Operating Income | -$7 | -$10 | -$11 | -$8 |
| % Margin | -27.7% | -78.6% | -193% | -403.9% |
| Other Income/Exp. Net | -$6 | -$3 | -$1 | -$1 |
| Pre-Tax Income | -$13 | -$13 | -$11 | -$10 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$13 | -$13 | -$11 | -$10 |
| % Margin | -51.3% | -99.1% | -204.4% | -467.5% |
| EPS | -0.8 | -0.93 | -0.7 | -0.7 |
| % Growth | 14% | -32.9% | 0% | – |
| EPS Diluted | -0.8 | -0.93 | -0.7 | -0.7 |
| Weighted Avg Shares Out | 16 | 14 | 13 | 12 |
| Weighted Avg Shares Out Dil | 16 | 14 | 13 | 12 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $2 | $2 | $1 | $1 |
| Depreciation & Amortization | $1 | $1 | $1 | $0 |
| EBITDA | -$10 | -$10 | -$9 | -$9 |
| % Margin | -38.6% | -77% | -166% | -410.9% |